Cargando…
Occurrence and outcomes of type 3 endoleaks in endovascular aortic repair within the Vascular Quality Initiative database
OBJECTIVES: Type 3 endoleaks (T3ELs) represent a lack of aneurysm protection from systemic pressure. Previous studies have found a ~2% incidence of T3EL after standard infrarenal endovascular aneurysm repair (EVAR); however, no prior studies with new-generation devices have been able to determine an...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785111/ https://www.ncbi.nlm.nih.gov/pubmed/33409487 http://dx.doi.org/10.1136/bmjsit-2020-000054 |
_version_ | 1783632389340135424 |
---|---|
author | Blakeslee-Carter, Juliet Beck, Adam Spangler, Emily |
author_facet | Blakeslee-Carter, Juliet Beck, Adam Spangler, Emily |
author_sort | Blakeslee-Carter, Juliet |
collection | PubMed |
description | OBJECTIVES: Type 3 endoleaks (T3ELs) represent a lack of aneurysm protection from systemic pressure. Previous studies have found a ~2% incidence of T3EL after standard infrarenal endovascular aneurysm repair (EVAR); however, no prior studies with new-generation devices have been able to determine an association between T3EL and clinical outcomes. Here we examine T3EL within the Society for Vascular Surgery Vascular Quality Initiative (VQI) to define rates of occurrence, rates and modes of reintervention, and clinical consequences of these endoleaks. DESIGN AND SETTING: Participants receiving infrarenal EVAR in the VQI from January 2003 to September 2018 were analyzed in a retrospective cohort study. PARTICIPANTS: Of 42 246 entries in the EVAR procedural registry, 41 604 had complete procedural information and were included in analysis. Of these, 36 082 had long-term follow-up, and 26 422 had follow-up (9–21 months per VQI reporting standards) with complete endoleak data recorded. INTERVENTIONS: All patients included in this study underwent an infrarenal EVAR. RESULTS: Within the VQI database, the rate of T3EL in infrarenal EVAR during index hospitalization was 0.37% (n=157/41 604), of which 85% were due to midgraft separation and 15% were due to fabric disruptions. Out of the 157 index hospitalization T3ELs, 4.5% (n=7) received procedural reintervention during that hospitalization, which accounted for 1% of all index hospitalization reinterventions. During the 21-month follow-up, the rate of incident T3EL was 0.7% (n=205/26 422), which accounted for 5% of all endoleaks seen during follow-up. Reinterventions for incident T3EL at follow-up were done in 30 patients (rate 0.1%), which accounted for 9% of endoleak reinterventions and 3.3% of all reinterventions. The presence of incident T3EL found during follow-up was associated with a significant decrease in 5-year survival (74% vs 80%, respectively; p=0.041) in Kaplan-Meier analysis. CONCLUSION: T3ELs rates at placement and follow-up remain low; however, the majority reported in long-term follow-up are incident and these incident endoleaks are associated with decreased survival in EVAR. |
format | Online Article Text |
id | pubmed-7785111 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-77851112021-01-05 Occurrence and outcomes of type 3 endoleaks in endovascular aortic repair within the Vascular Quality Initiative database Blakeslee-Carter, Juliet Beck, Adam Spangler, Emily BMJ Surg Interv Health Technol Original Research OBJECTIVES: Type 3 endoleaks (T3ELs) represent a lack of aneurysm protection from systemic pressure. Previous studies have found a ~2% incidence of T3EL after standard infrarenal endovascular aneurysm repair (EVAR); however, no prior studies with new-generation devices have been able to determine an association between T3EL and clinical outcomes. Here we examine T3EL within the Society for Vascular Surgery Vascular Quality Initiative (VQI) to define rates of occurrence, rates and modes of reintervention, and clinical consequences of these endoleaks. DESIGN AND SETTING: Participants receiving infrarenal EVAR in the VQI from January 2003 to September 2018 were analyzed in a retrospective cohort study. PARTICIPANTS: Of 42 246 entries in the EVAR procedural registry, 41 604 had complete procedural information and were included in analysis. Of these, 36 082 had long-term follow-up, and 26 422 had follow-up (9–21 months per VQI reporting standards) with complete endoleak data recorded. INTERVENTIONS: All patients included in this study underwent an infrarenal EVAR. RESULTS: Within the VQI database, the rate of T3EL in infrarenal EVAR during index hospitalization was 0.37% (n=157/41 604), of which 85% were due to midgraft separation and 15% were due to fabric disruptions. Out of the 157 index hospitalization T3ELs, 4.5% (n=7) received procedural reintervention during that hospitalization, which accounted for 1% of all index hospitalization reinterventions. During the 21-month follow-up, the rate of incident T3EL was 0.7% (n=205/26 422), which accounted for 5% of all endoleaks seen during follow-up. Reinterventions for incident T3EL at follow-up were done in 30 patients (rate 0.1%), which accounted for 9% of endoleak reinterventions and 3.3% of all reinterventions. The presence of incident T3EL found during follow-up was associated with a significant decrease in 5-year survival (74% vs 80%, respectively; p=0.041) in Kaplan-Meier analysis. CONCLUSION: T3ELs rates at placement and follow-up remain low; however, the majority reported in long-term follow-up are incident and these incident endoleaks are associated with decreased survival in EVAR. BMJ Publishing Group 2020-11-11 /pmc/articles/PMC7785111/ /pubmed/33409487 http://dx.doi.org/10.1136/bmjsit-2020-000054 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Original Research Blakeslee-Carter, Juliet Beck, Adam Spangler, Emily Occurrence and outcomes of type 3 endoleaks in endovascular aortic repair within the Vascular Quality Initiative database |
title | Occurrence and outcomes of type 3 endoleaks in endovascular aortic repair within the Vascular Quality Initiative database |
title_full | Occurrence and outcomes of type 3 endoleaks in endovascular aortic repair within the Vascular Quality Initiative database |
title_fullStr | Occurrence and outcomes of type 3 endoleaks in endovascular aortic repair within the Vascular Quality Initiative database |
title_full_unstemmed | Occurrence and outcomes of type 3 endoleaks in endovascular aortic repair within the Vascular Quality Initiative database |
title_short | Occurrence and outcomes of type 3 endoleaks in endovascular aortic repair within the Vascular Quality Initiative database |
title_sort | occurrence and outcomes of type 3 endoleaks in endovascular aortic repair within the vascular quality initiative database |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785111/ https://www.ncbi.nlm.nih.gov/pubmed/33409487 http://dx.doi.org/10.1136/bmjsit-2020-000054 |
work_keys_str_mv | AT blakesleecarterjuliet occurrenceandoutcomesoftype3endoleaksinendovascularaorticrepairwithinthevascularqualityinitiativedatabase AT beckadam occurrenceandoutcomesoftype3endoleaksinendovascularaorticrepairwithinthevascularqualityinitiativedatabase AT spangleremily occurrenceandoutcomesoftype3endoleaksinendovascularaorticrepairwithinthevascularqualityinitiativedatabase |